NEXEL Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nexel.co.kr
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of NP-011 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Drug: NP-011 (Single Ascending Dose Phase)Drug: NP-011 (Multiple Ascending Dose Phase)Other: NP-011 (Placebo)
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Nexel Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT05387499
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
News
No news found